Matches in SemOpenAlex for { <https://semopenalex.org/work/W3004768549> ?p ?o ?g. }
- W3004768549 endingPage "1020" @default.
- W3004768549 startingPage "1013" @default.
- W3004768549 abstract "Fluid overload (FO) grade ≥2 (more than 10% weight gain from baseline) has recently been recognized as an important toxicity associated with a high rate of nonrelapse mortality in recipients of allogeneic hematopoietic cell transplantation (AHCT). The causes for FO remain unclear. We hypothesized that endothelial damage, possibly due to treatments received prior to AHCT, may be associated with this toxicity and sought to determine whether the Endothelial Activation and Stress Index (EASIX) (defined as lactate dehydrogenase [U/L] × creatinine [mg/dL]/platelets [109 cells/L]) correlates with grade ≥2 FO in 2 cohorts of recipients of AHCT at our institution. We tested our hypothesis in a cohort of 145 consecutive recipients (study cohort) of AHCT transplant from HLA-haploidentical donors and validated the findings in a cohort of 449 (validation cohort) recipients of AHCT from HLA-matched donors who underwent transplantation between 2010 and 2015. Predictors of grade ≥2 FO were evaluated using competing risks regression in univariate analysis and classification and regression tree (CART) analysis in multivariate analysis. The cumulative incidence of grade ≥2 FO was estimated considering death as a competing risk. EASIX scores were evaluated based on log2-transformed values. Optimal predictive EASIX cutoff values were determined based on receiver operating characteristics curve analysis. Grade ≥2 FO occurred in 21% and 6% of the study and validation cohorts, respectively, with the majority of these cases being diagnosed before the day of AHCT. Median log2 EASIX score at admission was 2.4 (interquartile range [IQR], 1.3, 3.7) and 2.5 (IQR, 1.4, 3.9) in the 2 respective cohorts. In univariate analysis, high EASIX at admission was a significant predictor of grade ≥2 FO in the study (cutoff: 4.4, hazard ratio [HR] = 4.8, P < .001) and in the validation (cutoff: 4.3, HR = 4.8, P < .001) cohorts. The significant effect of EASIX persisted in multivariate CART analysis in the study (HR = 6.3, P < .001) and the validation (HR = 28, P = .002) cohorts. Additional predictors in multivariate analysis included body weight below 80 kg in recipients older than 55 years (HR = 4.5, P < .001) in the study cohort and diabetes (HR = 34, P = .001) and age >60 years (HR = 9.6, P = .04) in the validation cohort. At admission, the prevalence of EASIX score of >4.3 (18% versus 17%, P = .9) was not different between the diabetics and nondiabetics. EASIX score at admission is a significant predictor of grade ≥2 FO in recipients of AHCT from HLA-haploidentical or HLA-matched donors. Independently of EASIX, older patients with low weight were associated with increased risk of grade ≥2 FO for recipients of HLA-haploidentical transplants. For the HLA-matched cohort, diabetes and older age were associated with increased FO risk. These findings require validation in external cohorts." @default.
- W3004768549 created "2020-02-14" @default.
- W3004768549 creator A5001940718 @default.
- W3004768549 creator A5016928938 @default.
- W3004768549 creator A5038619722 @default.
- W3004768549 creator A5039986529 @default.
- W3004768549 creator A5047522685 @default.
- W3004768549 creator A5048913229 @default.
- W3004768549 creator A5088175930 @default.
- W3004768549 creator A5091083304 @default.
- W3004768549 date "2020-05-01" @default.
- W3004768549 modified "2023-10-03" @default.
- W3004768549 title "Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation" @default.
- W3004768549 cites W1578062386 @default.
- W3004768549 cites W2015698112 @default.
- W3004768549 cites W2034180131 @default.
- W3004768549 cites W2057364247 @default.
- W3004768549 cites W2072454523 @default.
- W3004768549 cites W2104723371 @default.
- W3004768549 cites W2112223256 @default.
- W3004768549 cites W2112539104 @default.
- W3004768549 cites W2116436674 @default.
- W3004768549 cites W2123095004 @default.
- W3004768549 cites W2125206586 @default.
- W3004768549 cites W2128082929 @default.
- W3004768549 cites W2129409822 @default.
- W3004768549 cites W2132418620 @default.
- W3004768549 cites W2159979844 @default.
- W3004768549 cites W2171745766 @default.
- W3004768549 cites W2177398380 @default.
- W3004768549 cites W2507831006 @default.
- W3004768549 cites W2606175639 @default.
- W3004768549 cites W2687087437 @default.
- W3004768549 cites W2738913822 @default.
- W3004768549 cites W2746503114 @default.
- W3004768549 cites W2782986513 @default.
- W3004768549 cites W2793913935 @default.
- W3004768549 cites W2801510276 @default.
- W3004768549 cites W2809534462 @default.
- W3004768549 cites W2884089544 @default.
- W3004768549 cites W2884218123 @default.
- W3004768549 cites W2884218159 @default.
- W3004768549 cites W2885952230 @default.
- W3004768549 cites W2912662883 @default.
- W3004768549 cites W2936688180 @default.
- W3004768549 cites W2950244989 @default.
- W3004768549 cites W2976365437 @default.
- W3004768549 cites W2989285417 @default.
- W3004768549 doi "https://doi.org/10.1016/j.bbmt.2020.01.028" @default.
- W3004768549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32045652" @default.
- W3004768549 hasPublicationYear "2020" @default.
- W3004768549 type Work @default.
- W3004768549 sameAs 3004768549 @default.
- W3004768549 citedByCount "30" @default.
- W3004768549 countsByYear W30047685492020 @default.
- W3004768549 countsByYear W30047685492021 @default.
- W3004768549 countsByYear W30047685492022 @default.
- W3004768549 countsByYear W30047685492023 @default.
- W3004768549 crossrefType "journal-article" @default.
- W3004768549 hasAuthorship W3004768549A5001940718 @default.
- W3004768549 hasAuthorship W3004768549A5016928938 @default.
- W3004768549 hasAuthorship W3004768549A5038619722 @default.
- W3004768549 hasAuthorship W3004768549A5039986529 @default.
- W3004768549 hasAuthorship W3004768549A5047522685 @default.
- W3004768549 hasAuthorship W3004768549A5048913229 @default.
- W3004768549 hasAuthorship W3004768549A5088175930 @default.
- W3004768549 hasAuthorship W3004768549A5091083304 @default.
- W3004768549 hasBestOaLocation W30047685491 @default.
- W3004768549 hasConcept C119060515 @default.
- W3004768549 hasConcept C126322002 @default.
- W3004768549 hasConcept C143998085 @default.
- W3004768549 hasConcept C144301174 @default.
- W3004768549 hasConcept C2777408962 @default.
- W3004768549 hasConcept C2911091166 @default.
- W3004768549 hasConcept C38180746 @default.
- W3004768549 hasConcept C71924100 @default.
- W3004768549 hasConcept C72563966 @default.
- W3004768549 hasConcept C88879693 @default.
- W3004768549 hasConceptScore W3004768549C119060515 @default.
- W3004768549 hasConceptScore W3004768549C126322002 @default.
- W3004768549 hasConceptScore W3004768549C143998085 @default.
- W3004768549 hasConceptScore W3004768549C144301174 @default.
- W3004768549 hasConceptScore W3004768549C2777408962 @default.
- W3004768549 hasConceptScore W3004768549C2911091166 @default.
- W3004768549 hasConceptScore W3004768549C38180746 @default.
- W3004768549 hasConceptScore W3004768549C71924100 @default.
- W3004768549 hasConceptScore W3004768549C72563966 @default.
- W3004768549 hasConceptScore W3004768549C88879693 @default.
- W3004768549 hasIssue "5" @default.
- W3004768549 hasLocation W30047685491 @default.
- W3004768549 hasOpenAccess W3004768549 @default.
- W3004768549 hasPrimaryLocation W30047685491 @default.
- W3004768549 hasRelatedWork W2004368639 @default.
- W3004768549 hasRelatedWork W2161996216 @default.
- W3004768549 hasRelatedWork W2314831286 @default.
- W3004768549 hasRelatedWork W2397394076 @default.
- W3004768549 hasRelatedWork W2614629048 @default.
- W3004768549 hasRelatedWork W2725144765 @default.